AbbVie Inc
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases
- ABBV Stock | AbbVie Q4 2021 Earnings Call
- ABBV Stock | AbbVie Q1 2022 Earnings Call
- ABBV Stock | AbbVie Inc Q3 2021 Earnings Call
- ABBV Stock | AbbVie Q4 2020 Earnings Call
- ABBV Stock | AbbVie, Inc. Q2 2021 Earnings Call
- AbbVie Inc ABBV CEO Rick Gonzalez on Q2 2020 Results
- ABBV Stock | AbbVie Q2 2020 Earnings Call
- ABBV Stock | AbbVie, Inc. Q2 2021 Earnings Call